InsiderTrades.com logo

ODTX Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $75,319,986.00
Insider Selling (Last 12 Months): $32,040.00

Odyssey Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Odyssey Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Odyssey Therapeutics Share Price & Price History

Current Price: $20.42
Price Change: ▼ Price Decrease of -2.92 (-12.51%)
As of 09/24/2026 09:41 AM ET

This chart shows the closing price history over time for ODTX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Odyssey Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/11/2026Nan LiDirectorBuy1,111,111$18.00$19,999,998.003,333,516View SEC Filing Icon  
5/11/2026Shelley ChuDirectorBuy11,111$18.00$199,998.0011,111View SEC Filing Icon  
5/11/2026Sr One Capital Management, LlcMajor ShareholderBuy555,555$18.00$9,999,990.001,831,383View SEC Filing Icon  
5/11/2026Sr One Capital Management, LlcMajor ShareholderSell1,780$18.00$32,040.00440,981View SEC Filing Icon  
5/11/2026Tpg Gp A, LlcMajor ShareholderBuy1,388,889$18.00$25,000,002.003,690,146View SEC Filing Icon  
5/8/2026Dimension Capital Ii, L.P.DirectorBuy1,111,111$18.00$19,999,998.003,333,516View SEC Filing Icon  
5/8/2026Jason HaasCFOBuy1,000$20.00$20,000.0062,908View SEC Filing Icon  
5/8/2026Jeffrey M. LeidenDirectorBuy5,000$20.00$100,000.00270,198View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Odyssey Therapeutics (NASDAQ:ODTX)

Odyssey Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/22/2026State Street Corp78,950$1.48M0.0%N/A0.164%Search for SEC Filing on Google Icon
9/9/2026The Manufacturers Life Insurance Company32,125$0.60M0.0%N/A0.067%Search for SEC Filing on Google Icon
9/2/2026Citadel Advisors LLC222,450$4.16M0.0%N/A0.463%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Odyssey Therapeutics Inc. is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases by developing medicines which are designed to precisely target disease pathology. Odyssey Therapeutics Inc. is based in BOSTON.
Read More on Odyssey Therapeutics

Today's Range

Now: $20.42
Low: $20.09
High: $21.09

50 Day Range

MA: $22.29
Low: $17.06
High: $28.76

52 Week Range

Now: $20.42
Low: $15.10
High: $29.05

Volume

3,768 shs

Average Volume

307,054 shs

Market Capitalization

$981.36 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Odyssey Therapeutics?

Odyssey Therapeutics' top insider shareholders include:
  1. Tpg Gp A, Llc (Major Shareholder)
  2. Dimension Capital Ii, LP (Director)
  3. Nan (Ln) Li (Director)
  4. Sr One Capital Management, Llc (Major Shareholder)
  5. Jeffrey M Leiden (Director)
  6. Jason Haas (CFO)
  7. Shelley Chu (Director)
Learn More about top insider investors at Odyssey Therapeutics.

Who are the major institutional investors of Odyssey Therapeutics?

Odyssey Therapeutics' top institutional investors include:
  1. Citadel Advisors LLC — 0.46%
  2. State Street Corp — 0.16%
  3. The Manufacturers Life Insurance Company — 0.07%
Learn More about top institutional investors of Odyssey Therapeutics stock.

Which institutional investors are buying Odyssey Therapeutics stock?

During the previous quarter, ODTX stock was purchased by institutional investors including:
  1. Citadel Advisors LLC
  2. State Street Corp
  3. The Manufacturers Life Insurance Company
During the last year, these company insiders have bought Odyssey Therapeutics stock:
  1. Tpg Gp A, Llc (Major Shareholder)
  2. Dimension Capital Ii, LP (Director)
  3. Nan (Ln) Li (Director)
  4. Sr One Capital Management, Llc (Major Shareholder)
  5. Jeffrey M Leiden (Director)
  6. Jason Haas (CFO)
  7. Shelley Chu (Director)
Learn More investors buying Odyssey Therapeutics stock.

Odyssey Therapeutics Active Insiders

Jason Haas
Jason Haas (Age 58)
CFO
1 recent trades
Shelley Chu
Shelley Chu
Director
1 recent trades
Jeffrey M Leiden
Jeffrey M Leiden
Director
1 recent trades
Nan (Ln) Li
Nan (Ln) Li
Director
1 recent trades